Accord Plasma (Intas Pharmaceuticals) Acquires Prothya Biosolutions Belgium

Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, announced it has agreed to acquire 100% of Prothya Biosolutions Belgium BV and all of its subsidiaries, following customary closing conditions including regulatory approvals. The deal, expected to close shortly and later described as completed, expands Accord/Intas’s plasma-derived medicinal product (PDMP) capabilities and global plasma manufacturing footprint.